Status:
COMPLETED
Safety and Pharmacokinetics of ELB353 in Healthy Men
Lead Sponsor:
Biotie Therapies Corp.
Conditions:
Healthy Volunteers
Eligibility:
MALE
18-45 years
Phase:
PHASE1
Brief Summary
The purpose of this trial is to study the safety and tolerability of repeated oral doses of ELB353, to evaluate the plasma levels of ELB353 and to study their effect on substances mediating inflammati...
Eligibility Criteria
Inclusion
- Healthy
Exclusion
- Concomitant medication
- Concomitant disease
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00977886
Start Date
September 1 2009
End Date
March 1 2010
Last Update
November 16 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Biotie investigational site
Berlin, State of Berlin, Germany, 14050